{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:12:21Z","timestamp":1791223941535,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.msard.2017.10.020","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T13:19:17Z","timestamp":1509628757000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Acute and long-term effects of fingolimod on heart rhythm and heart rate variability in patients with multiple sclerosis"],"prefix":"10.1016","volume":"19","author":[{"given":"Ruken \u00d6zge","family":"Akbulak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina C.","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin N.","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans O.","family":"Pinnschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Heesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris A.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2017.10.020_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0952-7915(02)00374-6","article-title":"FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity","volume":"14","author":"Brinkmann","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.msard.2017.10.020_bib2","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00007890-200109150-00002","article-title":"FTY720: altered lymphocyte traffic results in allograft protection","volume":"72","author":"Brinkmann","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.msard.2017.10.020_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0041-1345(00)02126-6","article-title":"FTY720: alters lymphocyte homing and protects allografts without inducing general immunosuppression","volume":"33","author":"Brinkmann","year":"2001","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.msard.2017.10.020_bib4","first-page":"213","article-title":"A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya)","volume":"12","author":"Chun","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.msard.2017.10.020_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2017.10.020_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.msard.2015.10.009","article-title":"The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis","volume":"5","author":"Datt","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2017.10.020_bib7","unstructured":"DiMarco J., O\u2019Connor P., Cohen J., Reder A., Zhang-Auberson L., Tang D., et al. (2012)\u00a0Fingolimod treatment initiation experience: cardiac and Holter electrocardiogram findings from three phase 3 studies. Presented at of the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 10\u201313 October 2012, Lyon, France [abstract P530]."},{"key":"10.1016\/j.msard.2017.10.020_bib8","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1177\/1352458511410344","article-title":"Delayed fingolimod-associated asystole","volume":"17","author":"Espinosa","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2017.10.020_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00415-013-7115-8","article-title":"Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study","volume":"261","author":"Gold","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2017.10.020_bib10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s004249900067","article-title":"Effects of sphingosine 1-phosphate on pacemaker activity in rabbit sino-atrial node cells","volume":"438","author":"Guo","year":"1999","journal-title":"Pfl\u00fcg. Arch.: Eur. J. Physiol."},{"key":"10.1016\/j.msard.2017.10.020_bib11","doi-asserted-by":"crossref","first-page":"e0132139","DOI":"10.1371\/journal.pone.0132139","article-title":"Central autonomic dysfunction delays recovery of fingolimod induced heart rate slowing","volume":"10","author":"Hilz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2017.10.020_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/01.CIR.94.2.122","article-title":"Sex-related differences in autonomic modulation of heart rate in middle-aged subjects","volume":"94","author":"Huikuri","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.msard.2017.10.020_bib13","unstructured":"Interim Analysis of the START Study \u2013 Extensive Electrocardiographic Monitoring Confirms the Good Cardiac Safety Profile of Fingolimod. Author(s): V. Limmroth, W. Haverkamp, R. Dechend, M. Lang, J. Haas, B. Wagner, S. Richter, H. Schieb, T. Ziemssen (Abstract release date: Sep 23, 2015) ECTRIMS Online Library. Limmroth V.\u00a0Oct 8, 2015; 115132."},{"key":"10.1016\/j.msard.2017.10.020_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2017.10.020_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/0091270004264165","article-title":"Multiple-dose FTY720: tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects","volume":"44","author":"Kovarik","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.msard.2017.10.020_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1600-6143.2005.00754.x","article-title":"The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I","volume":"5","author":"Koyrakh","year":"2005","journal-title":"Am. J. Transplant.: Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"11","key":"10.1016\/j.msard.2017.10.020_bib17","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2017.10.020_bib18","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1177\/1352458512438456","article-title":"Sudden unexpected death on fingolimod","volume":"18","author":"Lindsey","year":"2012","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2017.10.020_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/002215540205000507","article-title":"Cell type-specific localization of human cardiac S1P receptors","volume":"50","author":"Mazurais","year":"2002","journal-title":"J. Histochem. Cytochem.: Off. J. Histochem. Soc."},{"key":"10.1016\/j.msard.2017.10.020_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.coph.2006.09.008","article-title":"Sphingosine-1-phosphate signaling in the cardiovascular system","volume":"7","author":"Peters","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.msard.2017.10.020_bib21","doi-asserted-by":"crossref","first-page":"e0146190","DOI":"10.1371\/journal.pone.0146190","article-title":"Efficacy and safety of fingolimod in an unselected patient population","volume":"11","author":"Rasenack","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2017.10.020_bib22","series-title":"FDA Drug Safety Communication: Revised Recommendations for Cardiovascular Monitoring and Use of Multiple Sclerosis Drug Gilenya (fingolimod)","author":"US Food and Drug Administration","year":"2012"},{"key":"10.1016\/j.msard.2017.10.020_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.115.012427","article-title":"The sphingosine 1-phosphate receptor agonist fingolimod increases myocardial salvage and decreases adverse post-infarction left ventricular remodeling in a porcine model of ischemia-reperfusion","author":"Santos-Gallego","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.msard.2017.10.020_bib24","unstructured":"Simula, S., Laitinen, T., Laitinen, T.M., Tarkiainen, T. Hartikainen, P., 2016. Effect of Fingolimod on Cardiac Autonomic Regulation in Patients with Multiple sclerosis. pp. 1\u20136."},{"key":"10.1016\/j.msard.2017.10.020_bib25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","article-title":"Heart rate variability: standards of measurement, physiological interpretation, and clinical use","volume":"93","author":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology","year":"1996","journal-title":"Circulation"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034817302948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034817302948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:40:42Z","timestamp":1761900042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034817302948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":25,"alternative-id":["S2211034817302948"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2017.10.020","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute and long-term effects of fingolimod on heart rhythm and heart rate variability in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2017.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}